Photoreceptor structure and function in patients with congenital achromatopsia

Investigative Ophthalmology and Visual Science

Volumn 52, Issue 10, 2011, Pages 7298-7308

  Genead, Mohamed A ^a,b   Fishman, Gerald A ^a,b   Rha, Jungtae ^c   Dubis, Adam M ^c   Bonci, Daniela Mari O ^c,d   Dubra, Alfredo ^e   Stone, Edwin M ^f   Neitz, Maureen ^g   Carroll, Joseph ^c  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b Medical College of Wisconsin ^*

^c MEDICAL COLLEGE OF WISCONSIN   (United States)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

^e UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^f UNIVERSITY OF IOWA   (United States)

^g UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC NUCLEOTIDE GATED CHANNEL; TRANSDUCIN; CNGA3 PROTEIN, HUMAN; CNGB3 PROTEIN, HUMAN;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; COLOR BLINDNESS; COLOR VISION TEST; CONTROLLED STUDY; ELECTRORETINOGRAPHY; EYE EXAMINATION; FEMALE; GENETIC ANALYSIS; GENOTYPE PHENOTYPE CORRELATION; HUMAN; MALE; NUCLEOTIDE SEQUENCE; PERIMETRY; PHOTORECEPTOR CELL; PHOTORECEPTOR INNER SEGMENT; PHOTORECEPTOR OUTER SEGMENT; PIGMENT EPITHELIUM; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RETINA CONE; RETINA MACULA LUTEA; SCREENING; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; STIMULUS RESPONSE; VISUAL ACUITY; COLOR VISION DEFECT; EXON; GENETICS; MIDDLE AGED; MUTATION; OPTICAL COHERENCE TOMOGRAPHY; PATHOLOGY; PATHOPHYSIOLOGY; PHOTOSTIMULATION; PHYSIOLOGY;

ADOLESCENT; ADULT; COLOR PERCEPTION TESTS; COLOR VISION DEFECTS; CYCLIC NUCLEOTIDE-GATED CATION CHANNELS; DNA MUTATIONAL ANALYSIS; ELECTRORETINOGRAPHY; EXONS; FEMALE; HUMANS; MALE; MIDDLE AGED; MUTATION; PHOTIC STIMULATION; PHOTORECEPTOR CELLS, VERTEBRATE; POLYMERASE CHAIN REACTION; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY; VISUAL FIELD TESTS;

EID: 84856401869     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.11-7762     Document Type: Article

References (45)

1. Sharpe LT, Stockman A, Jagle H, et al. Opsin genes, cone photopigments and colour blindness. In: Gegenfurtner K, Sharpe LT, eds. Color Vision: From Genes to Perception. Cambridge, UK: Cambridge University Press; 1999:3-52.
2. Khan NW, Wissinger B, Kohl S, Sieving PA. CNGB3 achromatopsia with progressive loss of residual cone function and impaired rodmediated function. Invest Ophthalmol Vis Sci. 2007;48:3864-3871.
3. Pokorny J, Smith VC, Pinckers AJ, Cozijnsen M. Classification of complete and incomplete autosomal recessive achromatopsia. Graefes Arch Clin Exp Ophthalmol. 1982;219:121-130.
4. Nishiguchi KM, Sandberg MA, Gorji N, et al. Cone cGMP-gated channel mutations and clinical findings in patients with achromatopsia, macular degeneration, and other hereditary cone diseases. Hum Mutat. 2005;25:248-258.
5. Michaelides M, Hardcastle AJ, Hunt DM, Moore AT. Progressive cone and cone-rod dystrophies: phenotypes and underlying molecular genetic basis. Surv Ophthalmol. 2006;51:232-258.
6. Thiadens AA, Somervuo V, van den Born LI, et al. Progressive loss of cones in achromatopsia: an imaging study using spectral-domain optical coherence tomography. Invest Ophthalmol Vis Sci. 2010; 51:5952-5957.
7. Wissinger B, Gamer D, Jägle H, et al. CNGA3 mutations in hereditary cone photoreceptor disorders. Am J Hum Genet. 2001;69: 722-737.
8. Kohl S, Baumann B, Broghammer M, et al. Mutations in the CNGB3 gene encoding the beta-subunit of the cone photoreceptor cGMPgated channel are responsible for achromatopsia (ACHM3) linked to chromosome 8q21. Hum Mol Genet. 2000;9:2107-2116.
9. Chang B, Dacey MS, Hawes NL, et al. Cone photoreceptor function loss-3, a novel mouse model of achromatopsia due to a mutation in Gnat2. Invest Ophthalmol Vis Sci. 2006;47:5017-5021.
10. Rosenberg T, Baumann B, Kohl S, Zrenner E, Jorgensen AL, Wissinger B. Variant phenotypes of incomplete achromatopsia in two cousins with GNAT2 gene mutations. Invest Ophthalmol Vis Sci. 2004;45:4256-4262.
11. Thiadens AAHJ, den Hollander AI, Roosing S, et al. Homozygosity mapping reveals PDE6C mutations in patients with early-onset cone photoreceptor disorders. Am J Hum Genet. 2009;85:240-247.
12. Komáromy AM, Alexander JJ, Rowlan JS, et al. Gene therapy rescues cone function in congenital achromatopsia. Hum Mol Genet. 2010;19:2581-2593.
13. Alexander JJ, Umino Y, Everhart D, et al. Restoration of cone vision in a mouse model of achromatopsia. Nat Med. 2007;13:685-687.
14. Carvalho LS, Xu J, Pearson RA, et al. Long-term and age-dependent restoration of visual function in a mouse model of CNGB3-associated achromatopsia following gene therapy. Hum Mol Genet. 2011;20:3161-3175.
15. Galezowski X. Du diagnostic des Maladies des Yeux par la Chromatoscopie rétinienne: Précéde d'une Etude sur les Lois physiques et physiologiques des Couleurs [in French]. Paris: J.B. Baillière et Fils; 1868.
16. Larsen H. Demonstration mikroskopischer Präparate von einem monochromatischen Auge [in German]. Klin Monatsbl Augenheilkd. 1921;67:301-302.
17. Harrison R, Hoefnagel D, Hayward JN. Congenital total color blindness: a clinicopathological report. Arch Ophthalmol. 1960;64:685-692.
18. Falls HF, Wolter R, Alpern M. Typical total monochromasy: a histological and psychophysical study. Arch Ophthalmol. 1965;74: 610-616.
19. Glickstein M, Heath GG. Receptors in the monochromat eye. Vision Res. 1975;15:633-636.
20. Barthelmes D, Sutter FK, Kurz-Levin MM, et al. Quantitative analysis of OCT characteristics in patients with achromatopsia and blue-cone monochromatism. Invest Ophthalmol Vis Sci. 2006;47: 1161-1166.
21. Varsányi B, Somfai GM, Lesch B, Vámos R, Farkas A. Optical coherence tomography of the macula in congenital achromatopsia. Invest Ophthalmol Vis Sci. 2007;48:2249-2253.
22. Liang JZ, Williams DR, Miller DT. Supernormal vision and highresolution retinal imaging through adaptive optics. J Opt Soc Am A. 1997;14:2884-2892.
23. Roorda A. Applications of adaptive optics scanning laser ophthalmoscopy. Optom Vis Sci. 2010;87:260-268.
24. Godara P, Dubis AM, Roorda A, Duncan JL, Carroll J. Adaptive optics retinal imaging: emerging clinical applications. Optom Vis Sci. 2010;87:930-941.
25. Carroll J, Choi SS, Williams DR. In vivo imaging of the photoreceptor mosaic of a rod monochromat. Vision Res. 2008;48:2564-2568.
26. Marmor MF, Holder GE, Seeliger NW, Yamamoto S. Standard for clinical electroretinography (2003 update). Doc Ophthalmol. 2004;108:107-114.
27. Krill AE, Fishman GA. Acquired color vision defects. Trans Am Acad Ophthalmol Otolaryngol. 1971;75:1095-1111.
28. Tanna H, Dubis AM, Ayub N, et al. Retinal imaging using commercial broadband optical coherence tomography. Br J Ophthalmol. 2010;94:372-376.
29. Rha J, Schroeder B, Godara P, Carroll J. Variable optical activation of human cone photoreceptors visualized using a short coherence light source. Opt Lett. 2009;34:3782-3784.
30. Dubra A, Sulai Y. Reflective afocal broadband adaptive optics scanning ophthalmoscope. Biomed Opt Express. 2011;2:1757-1768.
31. Li KY, Roorda A. Automated identification of cone photoreceptors in adaptive optics retinal images. J Opt Soc Am A Opt Image Sci Vis. 2007;24:1358-1363.
32. McAllister JT, Dubis AM, Tait DM, et al. Arrested development: high-resolution imaging of foveal morphology in albinism. Vision Res. 2010;50:810-817.
33. Anastasakis A, McAnany JJ, Fishman GA, Seiple WH. Clinical value, normative retinal sensitivity values, and intrasession repeatability using a spectral-domain OCT/SLO microperimeter. Eye. 2011;25: 245-251.
34. Thiadens AA, Slingerland NW, Roosing S, et al. Genetic etiology and clinical consequences of complete and incomplete achromatopsia. Ophthalmology. 2009;116:1984-1989.
35. Thomas MG, Kumar A, Kohl S, Proudlock FA, Gottlob I. Highresolution in vivo imaging in achromatopsia. Ophthalmology. 2011;118:882-888.
36. Kohl S, Marx T, Giddings I, et al. Total colour blindness is caused by mutations in the gene encoding the alpha-subunit of the cone photoreceptor cGMP-gated cation channel. Nat Genet. 1998;19: 257-259.
37. Curcio CA, Sloan KR, Kalina RE, Hendrickson AE. Human photoreceptor topography. J Comp Neurol. 1990;292:497-523.
38. Grau T, Artemyev NO, Rosenberg T, et al. Decreased catalytic activity and altered activation properties of PDE6C mutants associated with autosomal recessive achromatopsia. Hum Mol Genet. 2011;20:719-730.
39. Rossi EA, Chung M, Dubra A, Hunter JJ, Merigan WH, Williams DR. Imaging retinal mosaics in the living eye. Eye. 2011;25:301-308.
40. Dubra A, Sulai Y, Norris JL, et al. Noninvasive imaging of the human rod photoreceptor mosaic using a confocal adaptive optics scanning ophthalmoscope. Biomed Opt Express. 2011;2:1864-1876.
41. Rha J, Dubis AM, Wagner-Schuman M, et al. Spectral domain optical coherence tomography and adaptive optics: imaging photoreceptor layer morphology to interpret preclinical phenotypes. Adv Exp Med Biol. 2010;664:309-316.
42. Stepien KE, Han DP, Schell J, Godara P, Rha J, Carroll J. Spectraldomain optical coherence tomography and adaptive optics may detect hydroxychloroquine retinal toxicity before symptomatic vision loss. Trans Am Ophthalmol Soc. 2009;107:28-33.
43. Smith VC, Pokorny J, Newell FW. Autosomal recessive incomplete achromatopsia with protan luminosity function. Ophthalmologica. 1978;177:197-207.
44. Wiszniewski W, Lewis RA, Lupski JR. Achromatopsia: the CNGB3 p. T383fsX mutation results from a founder effect and is responsible for the visual phenotype in the original report of uniparental disomy 14. Hum Genet. 2007;121:433-439.
45. Talcott KE, Ratnam K, Sundquist SM, et al. Longitudinal study of cone photoreceptors during retinal degeneration and in response to ciliary neurotrophic factor treatment. Invest Ophthalmol Vis Sci. 2011;52:2219-2226.